Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

KOS-862 enters phase Ib trial in combination with Paraplatin for solid tumors

July 29, 2004

Enrollment completed in STELLAR 2 trial of Xyotax

July 29, 2004

Novel propapoptotic agents newly developed at Aponetics

July 29, 2004

Novartis presents new VEGF inhibitors for cancer and ocular disorders

July 29, 2004

Merck researchers claim new tyrosine kinase regulators and their use

July 29, 2004

Promising antitumor activity reported for DRF-1042 in patients with refractory solid tumors

July 28, 2004

PBI-1402: a hematopoietic growth stimulant and chemoprotective agent

July 28, 2004

Korean team describes antitumor agents targeting Wnt-signaling pathways

July 28, 2004

Novel protein kinase inhibitors and their use in cancer therapy

July 27, 2004

DMAG enters phase I

July 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...